Metabolism of amyloid proteins

CIBA Foundation Symposia

Volumn , Issue 199, 1996, Pages 104-118

  Benson, M D ^a,b   Kluve Beckerman, B ^a   Liepnieks, J J ^a,b   Murrell, J R ^a   Hanes, D ^a   Uemichi, T ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN A1; PREALBUMIN; PROTEIN PRECURSOR; SERUM AMYLOID A; TRANSTHYRETIN RELATED AMYLOID FIBRIL PROTEIN, HUMAN; TRANSTHYRETIN-RELATED AMYLOID FIBRIL PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMYLOIDOSIS; ANIMAL; ARTICLE; BIOSYNTHESIS; GENETICS; HUMAN; METABOLISM; MOUSE;

ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOIDOSIS; ANIMALS; APOLIPOPROTEIN A-I; APOLIPOPROTEINS; HUMANS; MICE; PREALBUMIN; PROTEIN PRECURSORS; SERUM AMYLOID A PROTEIN;

EID: 0030330408     PISSN: 03005208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abrahamson M, Jonsdottir S, Olafsson I, Jensson O, Grubb A 1992 Hereditary cystatin C amyloid angiopathy: identification of the disease-causing mutation and specific diagnosis by polymerase chain reaction based analysis. Hum Genet 89:377-380
2. Benson MD, Dwulet FE 1983 Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis & Rheum 26:1493-1498
3. Berman M, Weiss M 1978 SAAM manual. US Department of Health, Education and Welfare. Washington, DC. (Publication no. (NJH) 78-180)
4. Citron M, Oltersdorf T, Haass C et al 1992 Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360:672-674
5. de Beer MC, de Beer FC, McCubbin WD, Kay CM, Kindy MS 1993 Structural prerequisites for serum amyloid A fibril formation. J Biol Chem 268:20606-20612
6. Glenner GG 1980a Amyloid deposits and amyloidosis. The β-fibrilloses. 1. N Engl J Med 302:1283-1292
7. Glenner GG 1980b Amyloid deposits and amyloidosis. The β-fibrilloscs. 2. N Engl J Med 302:1333-1343
8. 2-terminal sequence identity with only one of 2 serum amyloid protein (ApoSAA) gene products. J Exp Med 159:641-646
9. Jensson O, Thorsteinsson L, Bots GTAM et al 1986 Immunohistochemical comparison between the Dutch and the Icelandic form of hereditary central nervous system amyloid angiopathy. Acta Neurol Scand 73:312-313
10. Levin M, Franklin EC, Frangione B, Pras M 1972 Amino acid sequence of a major nonimmunoglobulin component of some amyloid fibrils. J Clin Invest 51:2773-2776
11. Liepnieks JJ, Kluve-Beckerman B, Benson MD 1995 Characterization of amyloid A protein in human secondary amyloidosis: the predominant deposition of serum amyloid Al. Biochem Biophys Acta 1270:81-86
12. Meek RL, Hoffman JS, Benditt EP 1986 Amyloidogenesis: one serum amyloid A isotype is selectively removed from the circulation. J Exp Med 163:499-510
13. Mullan M, Crawford F, Axelman K et al 1992 A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid. Nat Genet 1:345-347
14. Nichols WC, Dwulet FE, Liepnieks JJ, Benson MD 1988 Variant apolipoprotein A-I as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 156:762-768
15. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD 1990 A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 8:318-323
16. Oppenheimer JH, Surks MI, Bernstein G, Smith JC 1965 Metabolism of Iodine-131-labeled thyroxine-binding prealbumin in man. Science 149:748-750
17. IOWA, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 33:755-763
18. Skinner M, Connors LH, Rubinow A, Libbey C, Sipe JD, Cohell AS 1985 Lowered prealbumin levels in patients with familial amyloid polyneuropathy (FAP) and their non-affected but at risk relatives. Am J Med Sci 289:17-21
19. Sletten K, Westermark P, Natvig JB 1976 Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid. J Exp Med 143:993-998
20. Solomon A, Waldmann TA, Fahey JL, McFarlane AS 1964 Metabolism of Bence Jones proteins. J Clin Invest 43:103-117
21. Soutar AK, Hawkins PN, Vigushin DM et al 1992 Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 89:7389-7393
22. 717) mutants. Science 264:1336-1340
23. Uemichi T, Liepnieks JJ, Benson MD 1994 Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 93:731-736
24. Vahlquist A, Peterson PA, Wibell L 1973 Metabolism of the vitamin A transporting protein complex. 1. Turnover studies in normal persons and in patients with chronic renal failure. Eur J Clin Invest 3:352-362
25. Waldmann TA, Strober W, Mogielnicki RP 1972 The renal handling of low molecular weight proteins. J Clin Invest 51:2162-2174
26. Westermark P, Pitkanen P, Benson L, Vahlquist A, Olofsson BO, Cornwell GG III 1985 Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest 52:314-318